The new health craze at CIIE: “China Acceleration” builds a great wall of health_ 东方 Fortune.com



[ad_1]

Original title: New healthy fashion at CIIE: “China Acceleration” to build a healthy Great Wall

Editor’s note: once rareto importProductNow he is becoming an “old friend” in residents’ homes. Little by little changes in imported life are China’s step towards a wealthy society.societyThe “footnote” of happiness in China is also a new fad brought by the platform represented by the China International Import Expo. As China is accelerating the construction of a new development pattern with the national grand cycle as the main body and national and international double cycles promoting each other, the CIIE is playing an increasingly important role as the first national-level exhibition with world import theme.As of today, we have cooperated with China International Import Expo Bureau to release a series of reports on “My Imported Life” andnew mediaproduct, It tells the “big change” behind the “little story” of imported products.

Xinhua News Agency, Shanghai, October 31 (Reporter Zhou Rui and Sun Qing) “One is hard to find” early, and the exhibition area has been repeatedly expanded. The exhibition area for medical equipment and medicine and healthcare can be considered the “hottest” exhibition area at CIIE. Taking CIIE, vaccines, drugs, medical devices and even “invisible” as a starting pointmedical serviceAll are “speeding up” and increasingly becoming guardians of the health of Chinese residents.

There is no specific medication, and the pain index is even higher than postoperative pain and delivery. About 1.56 million new herpes zoster patients each year in China finally encounter the “nemesis” – the shingles vaccine is on the market.

At the second CIIE, the renowned pharmaceutical company GlaxoSmithKline brought the first approved shingles vaccine “Xinan Lishi” in China. After the meeting, this vaccine started the “acceleration” trip to China.

“The landing of the shingles vaccine reflects the ‘Chinese speed’ of introducing innovative drugs.” Sun Lei, director of GlaxoSmithKline China’s vaccine business, presented that “Xinan Lishi” was officially launched in June this year and that China is the fifth largest in the world. Countries and regions listed in the market, which benefited from China’s rapid approval. After its launch, in less than 4 months, this vaccine has finalized the online tender in 16 provinces. Currently, the shingles vaccine has been vaccinated in more than 10 cities across the country and continues to be rolled out across the country. .

GlaxoSmithKline is currently preparing for the third CIIE. this year,companyIt will bring dozens of strong blowsNew product, To showcase the patented vaccine adjuvant technology and the achievements of companies involved in the global fight against the new corona pneumonia epidemic.

“CIIE is an opportunity for us to demonstrate innovation. We look forward to bringing the latest vaccine products to more Chinese residents. We also hope that through CIIE, everyone can learn more about vaccines,” Sun Lei said.

The German pharmaceutical company Boehringer Ingelheim also benefits from the “acceleration” of Chinese approvals.

Recently, the new indication for the drug nintedanib developed by the German pharmaceutical company Boehringer Ingelheim was approved in China, just a month and a half later than in the EU. Boehringer Ingelheim Corporate Communicationsvice presidentYin Yuhan said that at the second CIIE, companies not only signed high-value drug purchase intentions, but also approved a number of innovative drugs in China to further accelerate.

This year, Boehringer Ingelheim successively established a digital innovation laboratory and an external innovation cooperation center in China in Shanghai. “In the next 5 years, we will be in ChinaCapital increase451 millionEUR.China is not only an important production base andconsumptionmarketIt is also the source of future global innovation. Yin Yuhan said that at the third CIIE, Boehringer Ingelheim will bring a variety of “first” products from China, including inhalation device for the treatment of chronic obstructive pulmonary drugs, “Noble” replaceable device and classical swine fever vaccines, etc.

Taking the CIIE as a starting point to “accelerate”, not only physical vaccines and medicines, but also health care in the “invisible” cloudService

At the second CIIE, Varian Medical demonstrated the 5G-based radiotherapy cloud system “Wisdom Cloud Interconnection”. Through the CIIE platform, this system has entered more than 200 Chinese cities, helping lower-tier hospitals to achieve cloud interconnection.

“The CIIE is a ‘guarantee’, which gives us great confidence to continue to root ourselves in the development of China.” Deputy Principal Warri Safety BallPresidentSemenBiggest chinaPresident Zhang Xiao introduced that companies are still overweight during the epidemicinvestmentIn China, the high-end linear accelerator production line exhibited at the second CIIE was officially completed in March this year, and the Varian Beijing base has officially become the world’s most comprehensive enterprise.product lineR&D and production base.

Zhang Xiao said that Varian signed 43 cooperative intentions at the second CIIE, of which about 50% have been transformed and implemented, and other projects also continue to advance. At the third CIIE, the company will bring the “Asia Pacific debut” of the ProBeam360 compact single-chamber proton therapy system and the “first in China” of drug-loaded microspheres used in interventional chemotherapy for liver cancer.

With the CIIE as a window, more global pharmaceutical companies are accelerating their entry into China. “We particularly appreciate the resilience manifested in the Chinese economy, especially in the new corona pneumonia epidemic.”MerckAccording to Chinese President An Gaobo, in July this year the company invested in a new life science laboratory in Shanghai Zhangjiang. At CIIE, you will not only make an appearance in the public area of ​​fighting the epidemic, but also announce a major project in the semiconductor industry. investment.

First exhibitorAbbottDiabetes business in Greater China and emerging Asian marketsGeneral ManagerXiang Yu introduced,AbbottThe enhanced version of the scan sugar measuring product “Shanten 2” and its supporting application “Shanten Bao” will make its “first exhibition in China”.HappenAutomatic blood glucose measurement. “AbbottIn the future, we will join with more industry partners to explore new innovative solutions and cooperation models to help China and the world fight the new corona pneumonia epidemic. “Xiang Yu said.

National Exhibition Center (Shanghai) Exhibition Department of International Import ExpoAssistant General ManagerWang Binjie commented that in the past three years, there have been many “loyal fans” in the medical equipment and medicine and healthcare exhibition area, including Merck,Eli lilly, AstraZeneca, Roche and other companies have signed a letter of intent to participate in the next three years with the China International Import Expo Bureau.

  

(Article source:Xinhuanet

(Editor in charge: DF062)

I solemnly declare: The purpose of this information disclosed by Oriental Fortune.com is to spread more information and has nothing to do with this booth.

[ad_2]